Physiologically based pharmacokinetic modeling of aldehyde oxidase drug-drug interactions mediated by erlotinib.
Saved in:
| Title: | Physiologically based pharmacokinetic modeling of aldehyde oxidase drug-drug interactions mediated by erlotinib. |
|---|---|
| Authors: | Heikkinen AT; Certara Predictive Technologies, Sheffield, United Kingdom., De Sousa Mendes M; Certara Predictive Technologies, Sheffield, United Kingdom., West MA; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc., Groton, Connecticut., Yee SW; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc., Groton, Connecticut., Gardner I; Certara Predictive Technologies, Sheffield, United Kingdom., Tang LWT; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc., Groton, Connecticut. Electronic address: lloydweitat.tang@pfizer.com. |
| Source: | Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2025 Aug; Vol. 53 (8), pp. 100113. Date of Electronic Publication: 2025 Jun 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9421550 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
